Author

Elmer Figueroa

Institution: Flagship Pioneering (United States)

Observed institution: Flagship Pioneering (United States)

ORCID: 0009-0005-0772-9632

Observed ORCID: 0009-0005-0772-9632

OpenAlex ID: A5077989982

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

2024 · William Senapedis, Kayleigh M. Gallagher, et al. · Nature Communications · 27

Abstract 2629: Epigenetic modulation of the MYC oncogene as a potential novel therapy for HCC

2022 · William Senapedis, Elmer Figueroa, et al. · Cancer Research · 2

Abstract 2417: Detection and quantification of site-specific DNA methylation from liquid biopsies as a pharmacodynamic biomarker of OTX-2002, a novel MYC-targeting epigenomic mRNA therapeutic

2024 · Justin Chen, William Senapedis, et al. · Cancer Research · 1

Effect of MYC-targeting programmable epigenetic mRNA therapeutics on TME and immunotherapy responses.

2023 · Yan Moore, William Senapedis, et al. · Journal of Clinical Oncology

Works count: 4

Citation count: 30

H-index: 2

I10-index: 1